- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06039618
Capabilities of Perinatal Healthcare Institutions in the Federation of Bosnia and Herzegovina
September 15, 2023 updated by: Antoine Naem, Evangelisches Krankenhaus Bethesda zu Duisburg
Capabilities of Perinatal Healthcare Institutions in Primary and Tertiary Care of Low Birth Weight Infants in the Federation of Bosnia and Herzegovina: A Cross-sectional Multicentric Study.
The aim of this study is to assess the level of the perinatal healthcare institution (PHI) where the newborns were delivered.
We included newborns of both genders that were born in the maternity wards in 10 cantons of the Federation of Bosnia and Herzegovina (FBiH).
From the PHI of the first and second level, 159 newborns were referred to the third level.
Out of a total of 159 LBWI referred from other PHI, only 19.5% LBWI were transported in less than 4 hours.
In second level PHI, most LBWI died in the first 12 hours after birth.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
22897
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tešanj, Bosnia and Herzegovina
- General Hospital Tesanj
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Newborns that were born in the maternity wards of the Federation of Bosnia and Herzegovina
Description
Inclusion Criteria:
- Newborns of both genders that were born in the maternity wards in 10 cantons of the FBiH
- A gestational age between 22 and 42 weeks, and a birth weight less than 2500g.
Exclusion Criteria:
- Infants younger than 22 weeks or older than 42 weeks.
- Infants whose mothers refused to give consent for participation in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Referred to a Centre of Higher Level
Those are the newborns that were referred at the time of delivery or within one week after birth to centers of higher organizational level.
|
Referral to Centre of Higher Organizational Level.
This means referral from a primary neonatal care center to a secondary one, or from the secondary to the tertiary center.
|
|
Treated at the Centre of Admission
Those are the newborns that were not referred to other centers and were treated in the health facility were the birth took place, and hospitalized in the same center until discharge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Referral to a centre of higher organizational level.
Time Frame: Before birth and up to 4 hours or more after delivery.
|
Referring the neonate with low birth weight to a more specialized centre.
|
Before birth and up to 4 hours or more after delivery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Anis Cerovac, M.D., General Hospital Tesanj
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2013
Primary Completion (Actual)
December 31, 2017
Study Completion (Actual)
December 31, 2017
Study Registration Dates
First Submitted
September 6, 2023
First Submitted That Met QC Criteria
September 9, 2023
First Posted (Actual)
September 15, 2023
Study Record Updates
Last Update Posted (Actual)
September 18, 2023
Last Update Submitted That Met QC Criteria
September 15, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 02-09/2-77/20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.